Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario
Abstract Background Currently biomarkers play an essential role in diagnosis, treatment, and management of cancer. In non-small cell lung cancer (NSCLC) determination of biomarkers such as ALK, EGFR, ROS1 or PD-L1 is mandatory for an adequate treatment decision. The aim of this study is to determine...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-06-01
|
| Series: | BMC Cancer |
| Online Access: | https://doi.org/10.1186/s12885-021-08407-1 |